A systematic review and meta-analysis evaluate treatment-emergent adverse events associated with trastuzumab deruxtecan in patients with breast cancer brain metastases.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/ild-seen-some-taking-adc-brain-cancer-metastases-2026a10003pg?src=rss
Author :
Publish date : 2026-02-05 13:48:00
Copyright for syndicated content belongs to the linked Source.
